McKesson Corporation (MCK) is a leading medical distribution business with stocks listed in the US. It opened the day at US$472.46 after a previous close of US$470.56. During the day the price has varied from a low of USD464.32 to a high of USD476.3493. The latest price was USD464.65 (25 minute delay). McKesson Corporation is listed on the NYSE. All prices are listed in US Dollars.
Our top pick for
US stocks
Our top pick for
Low costs
Our top pick for
Dividend investing
McKesson Corporation's shares were split on a 2:1 basis on 5 January 1998. So if you had owned 1 share the day before the split, the next day you would own 2 shares. This wouldn't directly have changed the overall worth of your McKesson Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for McKesson Corporation shares which in turn could have impacted McKesson Corporation's share price.
| Open | US$472.46 |
|---|---|
| High | US$476.3493 |
| Low | US$464.32 |
| Close | US$464.65 |
| Previous close | US$470.56 |
| Change | US$-5.91 |
| Change % | -1.256% |
| Volume | 798,862 |
| 52-week range | US$330.7966 - US$473.18 |
|---|---|
| 50-day moving average | US$450.0064 |
| 200-day moving average | US$403.4804 |
| Target price | US$499.33 |
| PE ratio | 18.2504 |
| Dividend yield | US$2.24 (0.54%) |
| Earnings per share (TTM) | US$25.28 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Historical closes compared with the last close of $464.65
| 1 week (2023-11-22) | 1.57% |
|---|---|
| 1 month (2023-11-02) | 3.81% |
| 3 months (2023-09-01) | 12.69% |
| 6 months (2023-06-02) | 19.09% |
| 1 year (2022-12-02) | 20.11% |
|---|---|
| 2 years (2021-12-02) | 110.81% |
| 3 years (2020-12-03) | 159.35% |
| 5 years (2018-12-03) | 265.41% |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing McKesson Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
McKesson Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, McKesson Corporation shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
McKesson Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6173. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into McKesson Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
McKesson Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$4.9 billion (£3.9 billion).
The EBITDA is a measure of a McKesson Corporation's overall financial performance and is widely used to measure a its profitability.
Over the last 12 months, McKesson Corporation's shares have ranged in value from as little as US$330.7966 up to US$473.18. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson Corporation's is 0.555. This would suggest that McKesson Corporation's shares are less volatile than average (for this exchange).
| Revenue TTM | US$291.1 billion |
|---|---|
| Operating margin TTM | 1.27% |
| Gross profit TTM | US$12.4 billion |
| Return on assets TTM | 4.23% |
| Return on equity TTM | 0% |
| Profit margin | 1.2% |
| Book value | -13.738 |
| Market capitalisation | US$61.4 billion |
TTM: trailing 12 months
Dividend payout ratio: 8.41% of net profits
Recently McKesson Corporation has paid out, on average, around 8.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.54% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson Corporation shareholders could enjoy a 0.54% return on their shares, in the form of dividend payments. In McKesson Corporation's case, that would currently equate to about $2.24 per share.
While McKesson Corporation's payout ratio might seem low, this can signify that McKesson Corporation is investing more in its future growth.
McKesson Corporation's most recent dividend payout was on 2 January 2024. The latest dividend was paid out to all shareholders who bought their shares by 30 November 2023 (the "ex-dividend date").
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like McKesson Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 23.8
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and McKesson Corporation's overall score of 23.8 (as at 01/01/2019) is pretty good – landing it in it in the 26th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like McKesson Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 9.12/100
McKesson Corporation's environmental score of 9.12 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 17.15/100
McKesson Corporation's social score of 17.15 puts it squarely in the 8th percentile of companies rated in the same sector. This could suggest that McKesson Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 12.53/100
McKesson Corporation's governance score puts it squarely in the 8th percentile of companies rated in the same sector. That could suggest that McKesson Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 4/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. McKesson Corporation scored a 4 out of 5 for controversy – the second-lowest score possible, reflecting that McKesson Corporation has a damaged public profile.
McKesson Corporation was last rated for ESG on: 2019-01-01.
| Total ESG score | 23.8 |
|---|---|
| Total ESG percentile | 26.02 |
| Environmental score | 9.12 |
| Environmental score percentile | 8 |
| Social score | 17.15 |
| Social score percentile | 8 |
| Governance score | 12.53 |
| Governance score percentile | 8 |
| Level of controversy | 4 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Looking for the best performing stocks in Australia? We update this list weekly.
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
Steps to owning and managing Microsoft shares from in Australia.
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Learn about the money market and everyday consumer money market products.
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
Follow these tips to find the best share trading platform for you.
